Table 2 Dxys for the different scoring systems and outcomes presented for t- and p-MDS (therapy-related and primary myelodysplastic syndromes): FAB (French-American-British classification), WHO (World Health Organization classification), IPSS-R (International Prognostic Scoring System-revised), WPSS-R (WHO-based Prognostic Scoring System-revised, cipssr (cytogenetic component of the IPSS-R), number of aberrations, and primary diagnosis.

From: Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

Score

Transformation free survival

Overall survival

Time to AML

 

t-MDS

p-MDS

t-MDS

p-MDS

t-MDS

p-MDS

FAB

0.19

0.30

0.17

0.28

0.24

0.42

WHO

0.24

0.29

0.19

0.26

0.41

0.44

IPSS-R

0.37

0.41

0.38

0.40

0.36

0.53

WPSS-R

0.35

0.38

0.33

0.36

0.40

0.51

cipssr

0.30

0.23

0.32

0.23

0.23

0.28

Number of aberrations

0.29

0.13

0.32

0.13

0.22

0.14

Primary diagnosis

0.05

/

0.05

/

0.03

/

Back to article page